comparemela.com
Home
Live Updates
Kristin Pawliw - Breaking News
Pages:
Latest Breaking News On - Kristin pawliw - Page 1 : comparemela.com
AbbVie - Phase 2 Study of Upadacitinib Alone or as a Combination Therapy Meets Primary and Key Secondary Endpoints in Patients with Systemic Lupus Erythematosus
NORTH CHICAGO - AbbVie today announced the results of the Phase 2 SLEek study evaluating upadacitinib alone and in combination [ABBV-599 high dose ] in adults with moderately to severely active. | June 1, 2023
Oklahoma
United-states
Roopal-thakkar
Kristin-pawliw
Joan-merrill
Exchange-commission
Lupus-erythematosus-national-assessment
Arthritis-clinical-immunology-research-program
European-congress
Oklahoma-medical-research-foundation
Flare-index
Lupus-low-disease-activity-state
vimarsana © 2020. All Rights Reserved.